Details of the Drug Reposition

General Information of This Drug (ID: DMAH59S)

Drug Name
Amonafide   DMAH59S
Synonyms Quinamed (TN)
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Breast cancer DIS7DPX1 2C60-2C65 Phase 3 [1]
Ovarian cancer DISZJHAP 2C73 Phase 3 [1]
Prostate cancer DISF190Y 2C82.0 Phase 3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00715637) Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDEStudy. U.S. National Institutes of Health.